Related Experiment Video
Updated: Mar 1, 2026

19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
19.4K
[The French medecine pricing committee].
1Université Paris Dauphine, 75000 Paris, France.
Annales Pharmaceutiques Francaises
|June 7, 2017
Summary
France
Area of Science:
- Health economics
- Pharmaceutical policy
- Public health
Background:
- The French Medicine Pricing Committee (CEPS) balances patient access to medicines with controlling healthcare expenditures.
- Drug pricing in France sees a significant decrease post-reimbursement registration.
- France faces a costly influx of innovative medicines, reflecting global price trends.
Purpose of the Study:
- To analyze the impact of CEPS's drug pricing and discount policies on health insurance finances.
- To evaluate the sustainability of providing innovative medicines under current cost-control measures.
- To explore strategies for managing expenditures with the rise of expensive new pharmaceuticals.
Main Methods:
- Analysis of drug price decreases and discounts implemented by CEPS between 2013 and 2015.
- Assessment of the cost of innovative medicines in France relative to Western Europe.
- Review of historical trends in medicine provision and expenditure control.
Main Results:
- CEPS's initiatives generated over €5 billion for health insurance accounts from 2013-2015.
- Despite high international prices, French medicine costs remain relatively low in Western Europe.
- Innovative medicines have been accessible to all patients in need over the past 15 years at a controlled cost.
Conclusions:
- France has successfully managed innovative medicine access and costs, but faces new challenges.
- A shift from price reduction to robust expenditure control policies is necessary.
- Exploring novel financing mechanisms is crucial for future sustainable medicine provision.
Related Concept Videos
Pharmaceutical Equivalents
231
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
231
Prescription, Nonprescription and Orphan Drugs
1.3K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.3K
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
54
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
54
Drug Dosage Regimen: Overview
4.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.6K
Drug Regulation
3.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.2K
Dosage Regimen: Fixed Dose
2.5K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.5K

